Security key
45783C101
Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL)
CUSIP: 45783C101
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, $0.000001 par value per share
- Total 13F shares
- 1,899,004
- Total 13F value
- $33,916,211
- Share change
- 0
- SEC-reported price per share
- $17.86
- Number of holders
- 1
- Shares outstanding
- 6,795,789
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
1
Top holders
1
TIL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Instil Bio, Inc. SEC filings
Instil Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45783C101
Recent filing periods:
Ownership snapshot
Top reported holders of TIL - Instil Bio, Inc. - Common Stock, $0.000001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Vivo Capital IX, LLC
Disclosed value leader
Curative Ventures V LLC
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G
13F
Lead comparable stake: 4.5%
13D/G row: Vivo Capital IX, LLC
Showing 1-6 of 15 holder rows.
Quick read
Vivo Capital IX, LLC leads the comparable SEC ownership view at 4.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Vivo Capital IX, LLC's linked filing trail.
Comparable ownership
Top 5
Vivo Capital IX, LLC
4.5%
Curative Ventures V LLC
28%
BML Capital Management, LLC
8.2%
CPMG Inc
6.3%
Vivo Capital, LLC
4.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Vivo Capital IX, LLC |
13D/G
|
4.5%
|
$7,169,276
292,743 shares
|
$0 | 30 Jun 2025 |
| Curative Ventures V LLC |
13F
Company
|
28%
|
$39,556,253
1,899,004 shares
|
— | 30 Jun 2025 |
| BML Capital Management, LLC |
13F
Company
|
8.2%
|
$11,141,946
534,899 shares
|
— | 30 Jun 2025 |
| CPMG Inc |
13F
Company
|
6.3%
|
$8,559,505
410,922 shares
|
— | 30 Jun 2025 |
| Vivo Capital, LLC |
13F
Company
|
4.5%
|
$6,097,837
292,743 shares
|
— | 30 Jun 2025 |
| Siren, L.L.C. |
13F
Individual
|
3.1%
|
$4,247,924
203,933 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
1,899,004
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
1
Q3 2025 holders
1
Holder diff
0
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend